Press release
Global Cardio-Protective Drug Market Research and Forecast, 2018-2023
Global Cardio-Protective Drugs Market Growth due to Increasing Prevalence of Chronic Heart Diseases.
According to OMR analysis, the global cardio-protective drugs market is estimated to grow at a significant CAGR during the forecast period (2018-2023). Factors motivating the growth of this market include increasing geriatric population and increase in excessive alcohol consumption & smoking. Other factors that are driving the growth of the market include increasing prevalence of chronic heart diseases and technological advancement in healthcare industry. High cost of medication and diagnostics procedure of heart disease are the major restraining factors restraining to the growth of this market
A full report of global cardio-protective drugs market is available at https://www.omrglobal.com/industry-reports/cardioprotective-drug-market/
Furthermore, the global cardio-protective drugs are segmented on the basis of application, type, distribution channels, treatment, and regional outlook. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Market Segmentation
1. Global Cardio-Protective Drugs Market By Treatment
• Cholesterol Lowering
• Revascularization
• Anti-Inflammatory
• Blood Thinners & Clot Busters
2. Global Cardio-Protective Drugs Market By Type
• Antiplatelets
• Ace Inhibitors & Arbs
• Beta-Blockers
• Polypills
• Statins & Others
3. Global Cardio-Protective Drugs Market By Application
• Arrhythmia
• Coronary Artery Disease
• Ischemic Heart Disease
• Cardiovascular Disease
• Hyperlipidaemia
• Peripheral Heart Disease
• Hypertension
4. Global Cardio-Protective Drugs Market By Distribution Channel
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
Region Covered
• North America (US and Canada)
• Europe (United Kingdom, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the World (Middle East & Africa and Latin America)
Company Profiled
• Astrazeneca Plc
• Amgen Inc.
• Bayer AG
• Boehringer Ingelheim GmBH
• Bristol-Myers Squibb Co.
• Daiichi Sankyo Co. Ltd.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Glaxosmithkline PLC
• Gilead Sciences, Inc.
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis AG
• Nissan Chemical Corp.
• Otsuka Holdings Co., Ltd.
• Pfizer, Inc.
• Sanofi S.A.
• Siemens Healthineer
• Takeda Pharmaceuticals Co. Ltd.
• Tenax Therapeutics, Inc.
For related reports please visit https://www.omrglobal.com/reports-category/pharmaceuticals/
For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/
About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
Contact us
Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com
India: +91 7803040404
Global:+1 6467557667
Indore-India-452010
Web: www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cardio-Protective Drug Market Research and Forecast, 2018-2023 here
News-ID: 1630160 • Views: …
More Releases from Orion Market Research
Permanent Magnet Motor Market Analysis Current Landscape and Future Outlook
The global Permanent Magnet Motor Market was valued at approximately USD 59.88 billion in 2024 and is anticipated to reach around USD 193.78 billion by 2034, growing at a CAGR of about 12.5% between 2025 and 2034.
Permanent Magnet Motor Market Overview
Permanent magnet motors utilize strong magnets like NdFeB and SmCo to generate magnetic fields without external excitation, delivering high energy efficiency, compactness, and superior power density. Their wide-ranging applications span…
Knee Replacement Market Size Unlocking New Opportunities for Success
The global Knee Replacement Market was valued at approximately USD 10.51 billion in 2024 and is projected to reach around USD 17.35 billion by 2034, reflecting a CAGR of about 5.14% from 2025 to 2034
Knee Replacement Market Overview
Knee replacement surgery is witnessing robust growth, largely driven by the rising prevalence of osteoarthritis and an aging global population. Technological advancements-such as robot-assisted procedures, 3D-printed and patient-specific implants, and minimally invasive…
Hyperautomation Market Accelerating Growth with Future Market Size Strategies an …
The global Hyperautomation Market was valued at approximately USD 56.11 billion in 2024 and is expected to soar to around USD 198.96 billion by 2033, expanding at a CAGR of about 16.5% from 2025 to 2033.
Hyperautomation Market Overview
Hyperautomation integrates advanced technologies like robotic process automation (RPA), AI, machine learning, and low-code platforms to enable end-to-end automation of complex business and IT workflows. Driven by digital transformation, rising demand for operational…
Exoskeleton Market Size Opportunities and Challenges for the Future
The global Exoskeleton Market was valued at USD 1.62 billion in 2024 and is projected to soar to approximately USD 29.96 billion by 2033, with an impressive CAGR of about 38.3% from 2025 to 2033.
Exoskeleton Market Overview
Exoskeleton systems are wearable robotic suits-either powered or passive-that augment human movement in healthcare, defense, industrial, and other sectors by enhancing strength, endurance, and mobility. The market growth is propelled by rising spinal cord…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
